Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health NGO Urges Future Dutch Govt To Act On High Drug Prices

Executive Summary

As the Dutch elections draw near, the civil society body Health Action International has launched a campaign calling on a future government to tackle what it calls “soaring” drug prices. The move follows the adoption of a European Parliament Resolution demanding a better balance between public health imperatives and industry interests.

You may also be interested in...

MEPs And Health Advocates Pile The Pressure On EU Drug Pricing

A European Parliament committee has approved a report outlining some possible solutions to the question of access to expensive new drugs, while Health Action International and several other NGOs have put emphasis on the need to ensure that where drugs developed by private companies use publicly funded research, they really serve the public good.

France Rejects Advice To Delay Second Dose Of Pfizer Vaccine

The French government has decided not to extend the recommended interval between the two doses of the Pfizer/BioNTech coronavirus vaccine. 

French HTA Body Backs Routine Six-Week Interval In COVID-19 Vaccine Dosing

France's health technology assessment body says that delaying by six weeks the second dose of the two mRNA vaccines approved for use against COVID-19 would allow at least 700,000 more people to receive their jab in the first month.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts